Institute for Policy Research, University of Bath, Bath.
Department of Sociology, Manchester Metropolitan University, Manchester, UK.
Curr Opin Endocrinol Diabetes Obes. 2021 Dec 1;28(6):630-635. doi: 10.1097/MED.0000000000000676.
As evidence continues to emerge of the harms associated with nonmedical androgen use, this review explores the implications from recent studies for designing strategies to reduce harm and support good health amongst androgen users.
Studies have predominantly come from researchers in the UK and Australia. Major themes include questioning the scope and content of harm reduction strategies and identifying approaches to improve engagement between the androgen using community and healthcare providers. Findings suggest that a broader range of interventions and forms of advice are needed than are commonly provided. This must be supported by efforts to increase opportunities to deliver harm reduction through new engagement approaches, better relationships with health professionals and more guidance on identifying and managing associated adverse health impacts.
A fully developed harm reduction-based response to nonmedical androgen use will be one that not only seeks to reduce risk of bloodborne virus transmission and injecting-related harms, but that considers the range of needs amongst the diverse community of androgen users and respects their decisions and rights. Co-producing interventions with members of this community will help develop effective and engaging approaches. Rigorous studies are needed to evaluate new harm reduction interventions as well as those already delivered.
随着越来越多的证据表明非医学用途雄激素使用会带来危害，本综述探讨了近期研究对制定策略以减少雄激素使用者的危害和促进健康的意义。
这些研究主要来自英国和澳大利亚的研究人员。主要主题包括质疑减少危害策略的范围和内容，并确定改善雄激素使用者社区与医疗保健提供者之间的参与度的方法。研究结果表明，需要提供比通常提供的更广泛的干预措施和形式的建议。这必须通过努力增加通过新的参与方法提供减少危害的机会来提供支持，与卫生专业人员建立更好的关系，并就识别和管理相关的不良健康影响提供更多指导。
全面的基于减少危害的非医学用途雄激素使用应对措施不仅要寻求降低血源性病毒传播和注射相关危害的风险，还要考虑到雄激素使用者群体的多样性需求，并尊重他们的决策和权利。与该群体的成员共同制定干预措施将有助于制定有效和吸引人的方法。需要进行严格的研究来评估新的减少危害干预措施以及已经提供的干预措施。
